3-38477382-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001106.4(ACVR2B):c.148G>A(p.Glu50Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000254 in 1,614,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001106.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACVR2B | ENST00000352511.5 | c.148G>A | p.Glu50Lys | missense_variant | Exon 2 of 11 | 1 | NM_001106.4 | ENSP00000340361.3 | ||
ACVR2B | ENST00000461232.1 | n.3937G>A | non_coding_transcript_exon_variant | Exon 1 of 10 | 1 | |||||
ACVR2B | ENST00000465020.5 | n.152G>A | non_coding_transcript_exon_variant | Exon 2 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251202Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135804
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727240
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74486
ClinVar
Submissions by phenotype
Heterotaxy, visceral, 4, autosomal Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 50 of the ACVR2B protein (p.Glu50Lys). This variant is present in population databases (rs371445433, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ACVR2B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1406908). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACVR2B protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at